Publications (876)
-
Primary Prevention of Congenital Anomalies: Recommendable, Feasible and Achievable
Primary Prevention of Congenital Anomalies: Recommendable, Feasible and Achievable
Taruscio D, Mantovani A, Carbone P, Barisic I, Bianchi F, Garne E, Nelen V, Neville A, Wellesley D, Dolk H
Public Health Genomics, 2015
Subjects: Prevention & Risk Factors -
Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: A European register-based study
Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: A European register-based study
Wemakor, A, Casson K, Garne E, Bakker M, Addor M-C, Arriola L, Gatt M, Khoshnood B, Klungsoyr K, Nelen V, O'Mahony M, Pierini A, Rissmann A, Tucker D, Boyle B, de Jong-van den Berg L, Dolk H
European Journal of Epidemiology, 2015
Subjects: Medication During Pregnancy -
The Association of H1N1 Pandemic Influenza with Congenital Anomaly Prevalence in Europe: An Ecological Time Series Study.
The Association of H1N1 Pandemic Influenza with Congenital Anomaly Prevalence in Europe: An Ecological Time Series Study.
Luteijn M, Addor M-C, Arriola L, Bianchi F, Garne E, Khoshnood B, Nelen V, Neville A, Queisser-Luft A, Rankin J, Rounding C, Verellen-Dumoulin C, de Walle H, Wellesley D, Yevtushok L, de Jong-van den Berg L, Morris J, Dolk H, Wreyford B
Epidemiology, 2015 , 26: (6) 853 - 861 -
The effect of H1N1 pandemic influenza on congenital anomaly prevalence in Europe: an ecological time series study
The effect of H1N1 pandemic influenza on congenital anomaly prevalence in Europe: an ecological time series study
Dolk H
Epidemiology, 2015
Subjects: Prevalence & Perinatal Mortality
Anomalies: Respiratory -
The increasing incidence of foetal echogenic congenital lung malformations: an observational study
The increasing incidence of foetal echogenic congenital lung malformations: an observational study
Stocker LJ, Wellesley D, Stanton MP, Parasuraman R, Howe DT
Prenatal Diagnosis, 2015 , 35: 148 - 153
Anomalies: Respiratory -
Using scan statistics for congenital anomalies surveillance - the EUROCAT methodology
Using scan statistics for congenital anomalies surveillance - the EUROCAT methodology
Teljeur C, Kelly A, Loane M, Densem J, Dolk H
European Journal of Epidemiology, 2015
Subjects: EUROCAT Overview -
Analysis of the Born in Bradford birth cohort
Analysis of the Born in Bradford birth cohort
Garne E, Morris J
The Lancet, 2014 , 383: 122 - 123
Subjects: Clusters and Trends -
Antenatal screening for Down Syndrome and other chromosomal abnormalities: increasingly complex issues
Antenatal screening for Down Syndrome and other chromosomal abnormalities: increasingly complex issues
Dolk H, Wellesley D
Archives of Disease in Childhood - Fetal and Neonatal Edition, 2014 , 99: (1) F2 - F3
Subjects: Prenatal Screening & Diagnosis, Prevention & Risk Factors
Anomalies: Chromosomal (other than Down Syndrome), Down Syndrome -
Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies
Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies
Lagan B, Dolk H, White B, Uges D, Sinclair M
Pharmacoepidemiology and Drug Safety, 2014 , 23: 411 - 418
Subjects: Medication During Pregnancy, Prevention & Risk Factors -
Early pregnancy exposure to antihistamines and risk of congenital heart defects: results of two case-control studies
Early pregnancy exposure to antihistamines and risk of congenital heart defects: results of two case-control studies
Smedts HPM, de Jonge, L, Bandola SJG, Baardman ME, Bakker M, Stricker B, Steegers-Theunissen RP
European Journal of Epidemiology, 2014
Subjects: Medication During Pregnancy, Prevalence & Perinatal Mortality, Prevention & Risk Factors
Anomalies: Congenital Heart Anomalies